Biochips (Microarrays/Lab-on-Chip) Global Market

2015

IQ4I Research & Consultancy Pvt. Ltd.

[email protected]

www.iq4i.com

– Forecast to 2021

Copyright © 2015 IQ4I

All Rights Reserved. This document contains highly confidential

information and is the sole property of IQ4I. No part of it may be

circulated, copied, quoted, or otherwise reproduced without the

approval of IQ4I.

[TYPES (Microarrays and Lab-on-Chip (LOC)/Microfluidics),

PRODUCTS (Instruments, Reagents & Consumables, Software and

Services) APPLICATIONS (Diagnostics, Drug discovery and

development, Research, Forensic and Others), END-USERS

(Diagnostic laboratories, Pharmaceutical & Biotech companies,

CRO’s, Academic and research labs and Others), REGIONAL (North

America, Europe, Asia Pacific and Rest of the World)]

Bio-Chips (Microarrays/Lab-on-Chip) Global Market

IQ4I Research & Consultancy Pvt. Ltd. Page 2


–Forecast to 2021



–Forecast to 2021



–Forecast to 2021



–Forecast to 2021



–Forecast to 2021



–Forecast to 2021



–Forecast to 2021



–Forecast to 2021



–Forecast to 2021



–Forecast to 2021



–Forecast to 2021



–Forecast to 2021

1.1 REPORT DESCRIPTION

Biochips come handy as thousands of experiments are performed on a small chip with a solid

platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as

its application varies from high throughput screening in drug discovery to personalized

medicine.

The global biochips market is broadly classified as micro arrays and lab on chips based on its

type. Biochips market is segmented on the basis of application as diagnostic, drug discovery

and development, research, forensic and others. Based on the products the biochips market is

further segmented into instruments, reagents and consumables, software and services.

The global biochips market is expected to grow at a CAGR of around XX% from 2015 to 2021.

Revolution in the field of genomics, proteomics as well as rapid drug discovery increased the

demand for biochips. In addition, increase in diagnosis and treatment of cancer and genetic

diseases, approval for personalized medicines and invention of novel technologies in biochips

drives the market of biochips. Standardization and quality assurance of biochips, technological

ease in handling the biochips especially in the areas of diagnosis and treatment, high cost along

with ethical and social issues hinders the market growth.

Lifestyle changes owing to increase in cancer, diabetes and hypertension patients, early

diagnosis and treatment of diseases, advancement of biochips with its wide application areas

shows that biochip market has vast opportunities in the coming years.

North America accounts for the highest market share followed by Europe. Steep rise in genetic

diagnosis, huge corporate outsourcing for drug discovery, increase in personalized medicines

and favourable government policies makes U.S. the leader of Biochips market. However, Asian

countries especially India and China’s are the fast growing regions with its growing demand for

biochips and increasing research investments.

Major players in biochips market include Affymetrix, Inc. (U.S.), Agilent Technologies (U.S.),

Bio-Rad Laboratories (U.S.), Cepheid, Inc. (U.S.), Fluidigm Corporation (U.S.), GE Healthcare

(U.K.), Hoffman-La-Roche (Switzerland), Illumina, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and

Thermo Fisher Scientific, Inc. (U.S.).



–Forecast to 2021

The report provides an in depth market analysis of the above mentioned segments across the

following regions:

North America

Europe

Asia-Pacific

Rest of the World (RoW)



–Forecast to 2021

TABLE 1

BIOCHIPS GLOBAL MARKET REVENUE, BY REGION,

(2013-2021) ($MN)

Region 2013 2014 2015 2021 CAGR (%)

(2015-2021)

North America XX XX XX XX XX

Europe XX XX XX XX XX

Asia-Pacific XX XX XX XX XX

RoW XX XX XX XX XX

Total XX XX XX 13,129 XX

Source: American Genetic Association (AGA), Genome Wide Association (GWA), American Society of Gene Therapy

(ASGT), Nanotechnology and Integrated Microsystems Associations (NIMA), International Electrotechnical

Commission (IEC), MEMS Associations, World Health Organization (WHO), Industry expert Interviews, and IQ4I

analysis

North America commanded the largest revenue of $XX million of the global biochips market in

2014. The market is expected to grow at a CAGR of 15% from 2015 to 2021 to reach $XX

million by 2021. Asia Pacific is expected to grow at a strong CAGR of XX% during the forecast

period.



–Forecast to 2021

TABLE 2

BIOCHIPS GLOBAL MARKET REVENUE, BY TYPE,

(2013-2021) ($MN)

Type 2013 2014 2015 2021 CAGR (%)

(2015-2021)

Microarrays XX XX XX XX XX

Lab-on-chips XX XX XX XX XX

Total XX XX XX XX XX




analysis

Microarrays commanded the largest revenue of $XX million of the global biochips market in

2014. The market is expected to grow at a CAGR of XX% from 2015 to 2021 to reach $XX

million by 2021. Lab-on-chips are expected to grow at a strong CAGR of XX% during the

forecast period.



–Forecast to 2021

FIGURE 1

BIOCHIPS GLOBAL MARKET REVENUE, BY PRODUCTS,

(2014 V’S 2021) ($MN)

Instruments Reagent and consumables Software Services

2014

2021

Ma

rke

t si

ze (

$ M

n)



–Forecast to 2021

TABLE 3

BIOCHIPS GLOBAL MARKET REVENUE, BY APPLICATION TYPE

(2013-2021) ($MN)

Type 2013 2014 2015 2021 CAGR (%)

(2015-2021)

Diagnostics XX XX XX XX XX

Drug discovery and development XX XX XX XX XX

Research XX XX XX XX XX

Forensics XX XX XX XX XX

Others XX XX XX XX XX





analysis

Diagnostics commanded the largest revenue of $XX million of the global biochips application

market in 2014. The market is expected to grow at a highest CAGR of XX% from 2015 to 2021

to reach $XX million by 2021.



–Forecast to 2021

TABLE 4

BIOCHIPS GLOBAL MARKET REVENUE, BY END USERS TYPE,

(2013-2021) ($MN)

Type 2013 2014 2015 2021 CAGR (%)

(2015-2021)

Pharmaceuticals & biotech companies XX XX XX XX XX

CRO's XX XX XX XX XX

Academic & research laboratories XX XX XX XX XX

Diagnostic laboratories XX XX XX XX XX

Others XX XX XX XX XX





analysis

Diagnostic laboratories commanded the largest revenue of $XX million of the global biochips

end users market in 2014. The market is expected to grow at a CAGR of XX% from 2015 to

2021 to reach $XX million by 2021. Pharmaceuticals and biotech companies are expected to

grow at a strong double digit CAGR of XX% during the forecast period.



–Forecast to 2021

Disclaimer: IQ4I strategic analysis services are limited publications containing valuable market

information provided to a select group of customers in response to orders. Our customers

acknowledge, when ordering, that IQ4I strategic analysis services are for our customers’

internal use and not for general publication or disclosure to third parties. Quantitative market

information is based primarily on interviews and therefore, is subject to fluctuation.

IQ4I does not endorse any vendor, product or service depicted in its research publications. IQ4I

strategic analysis publications consist of the opinions of IQ4I' research and should not be

construed as statements of fact. IQ4I disclaims all warranties, expressed or implied, with

respect to this research, including any warranties of merchantability or fitness for a particular

purpose.

IQ4I takes no responsibility for any incorrect information supplied to us by manufacturers or

users.

All trademarks, copyrights and other forms of intellectual property belong to their respective

owners and may be protected by copyright. Under no circumstance may any of these be

reproduced in any form without the prior written agreement of their owner.

No part of this strategic analysis service may be given, lent, resold or disclosed to non-

customers without written permission.

Reproduction and/or transmission in any form and by any means including photocopying,

mechanical, electronic, recording or otherwise, without the permission of the publisher is

prohibited.

For information regarding permission, contact:

Tel: +91 80 60500229

Email: [email protected]

mailto:[email protected]